Emanuela Risi

Prato, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study.

CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study.

Journal: Journal of geriatric oncology

Published: November 25, 2025

A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing.

A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing.

Journal: Genome medicine

Published: August 01, 2025

Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients.

Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients.

Journal: Future oncology (London, England)

Published: October 21, 2024

Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial.

Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 06, 2024

Clinical trials in older patients with cancer - typical challenges, possible solutions, and a paradigm of study design in breast cancer.

Clinical trials in older patients with cancer - typical challenges, possible solutions, and a paradigm of study design in breast cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: March 18, 2024

Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.

Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.

Journal: JCO precision oncology

Published: March 01, 2024

Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.

Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.

Journal: Frontiers in oncology

Published: January 27, 2023

Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients.

Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients.

Journal: Translational oncology

Published: June 02, 2022

PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer.

PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer.

Journal: NPJ breast cancer

Published: June 30, 2021

PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.

PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.

Journal: Therapeutic advances in medical oncology

Published: May 18, 2021

Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer.

Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer.

Journal: International journal of molecular sciences

Published: April 08, 2021

Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.

Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.

Journal: Breast cancer research : BCR

Published: October 16, 2020

Showing 1-12 of 40

Last Updated: 09/26/2026